Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$77.60M
Total Bought:
$34.24M
Total Sold:
$58.97M
Net Transaction:
-$24.73M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MINERVA NEUROSCIENCES INC1,655,5002,175,802+520,302$9.97M$12.08M15.56%+$2.10M
PROMIS NEUROSCIENCES INC414,219620,319+206,100$5.26M$8.16M10.52%+$2.90M
FIRST TRACKS BIOTHERAPEUTICS0284,287+284,287$0$5.72M7.37%+$5.72M
Axsome Therapeutics, Inc.(AXSM)016,493+16,493$0$4.04M5.20%+$4.04M
ASSEMBLY BIOSCIENCES INC0140,000+140,000$0$3.85M4.96%+$3.85M
WHITEHAWK THERAPEUTICS INC817,939817,9390$2.82M$3.75M4.83%+$924.3K
Edgewise Therapeutics, Inc.(EWTX)161,00083,300-77,700$5.07M$3.38M4.36%-$1.69M
CLIMB BIO INC0249,172+249,172$0$3.25M4.19%+$3.25M
Kura Oncology, Inc.(KURA)0290,000+290,000$0$3.18M4.10%+$3.18M
CYTOMX THERAPEUTICS INC.900,000775,000-125,000$4.23M$2.91M3.75%-$1.32M
AVALO THERAPEUTICS INC0150,000+150,000$0$2.77M3.57%+$2.77M
PALISADE BIO INC01,229,000+1,229,000$0$2.57M3.31%+$2.57M
SOLID BIOSCIENCES INC766,974255,959-511,015$5.52M$2.56M3.30%-$2.97M
AN2 THERAPEUTICS INC526,315526,3150$1.80M$2.55M3.28%+$747.4K
UroGen Pharma Ltd.(URGN)202,12469,183-132,941$3.63M$2.55M3.28%-$1.09M
PERSPECTIVE THERAPEUTICS INC926,557743,958-182,599$3.86M$2.54M3.27%-$1.33M
IDEAYA Biosciences, Inc.(IDYA)067,500+67,500$0$2.52M3.24%+$2.52M
INVENTIVA SA745,300634,800-110,500$4.14M$2.40M3.09%-$1.74M
ALUMIS INC166,95976,459-90,500$3.68M$2.15M2.77%-$1.53M
OVID THERAPEUTICS INC2,818,459624,561-2,193,898$6.26M$1.68M2.17%-$4.58M
EUPRAXIA PHARMACEUTICALS INC660,375252,175-408,200$4.78M$1.67M2.15%-$3.11M
IBIO INC0390,147+390,147$0$682.8K0.88%+$682.8K
TRAWS PHARMA INC0786,236+786,236$0$663.0K0.85%+$663.0K
ABIVAX Société Anonyme(ABVX)33,7120-33,712$3.75M$0—-$3.75M
CAPRICOR THERAPEUTICS INC113,8990-113,899$3.46M$0—-$3.46M
COMPASS Pathways plc(CMPS)1,045,0000-1,045,000$5.78M$0—-$5.78M
INHIBIKASE THERAPEUTICS INC1,325,0000-1,325,000$2.23M$0—-$2.23M
Praxis Precision Medicines, Inc.(PRAX)32,8100-32,810$10.57M$0—-$10.57M
RELMADA THERAPEUTICS INC210,5250-210,525$1.47M$0—-$1.47M
SOLENO THERAPEUTICS INC200,0000-200,000$6.70M$0—-$6.70M
Tarsus Pharmaceuticals, Inc.(TARS)80,8590-80,859$5.67M$0—-$5.67M
Page 1 of 1